BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3258201)

  • 1. Natural killer cells in Behçet's disease.
    Hamzaoui K; Ayed K; Hamza M; Touraine JL
    Clin Exp Immunol; 1988 Jan; 71(1):126-31. PubMed ID: 3258201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of a minor subpopulation of peripheral blood lymphocytes (T8+/Leu 7+) in patients with haemophilia.
    Ziegler-Heitbrock HW; Schramm W; Stachel D; Rumpold H; Kraft D; Wernicke D; von der Helm K; Eberle J; Deinhardt F; Rieber EP
    Clin Exp Immunol; 1985 Sep; 61(3):633-41. PubMed ID: 4075588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
    Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
    J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
    J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of natural killer cell function with Leu 7 reactivity in patients with humoral immunodeficiency.
    Huwyler T; Morell A; Hirt A; Ricci C; Wagner HP; Barandun S
    Clin Exp Immunol; 1984 Jun; 56(3):486-92. PubMed ID: 6744658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigen determinants in subpopulations of peripheral blood NK- and T-cells separated by Percoll density fractionation.
    Schlesinger M; Lew F; Bekesi JG
    J Clin Lab Immunol; 1984 Apr; 13(4):195-202. PubMed ID: 6204054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
    Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T; Cooper MD; Balch CM
    J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic expression of natural killer cell associated membrane antigens and cytolytic function of peripheral blood cells from different aged humans.
    Bender BS; Chrest FJ; Adler WH
    J Clin Lab Immunol; 1986 Sep; 21(1):31-6. PubMed ID: 3100806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activity in patients with inflammatory bowel disease.
    Egawa S; Hiwatashi N
    J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
    Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
    Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
    Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
    J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma.
    Kakumu S; Hirofuji H; Fuji A; Tahara H; Yoshioka K
    J Clin Lab Immunol; 1988 May; 26(1):29-32. PubMed ID: 2846843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
    Smith BR; Rosenthal DS; Ault KA
    Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.